SCHEMBL11210339

SCHEMBL11210339

CSc1ncnc2c1cnn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADA P00813 1/20 0.50
▸ ATG7 O95352 1/20 0.49
▸ TP53 P04637 1/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.48
▸ ADK P55263 4/20 0.48
▸ SLC29A1 Q99808 2/20 0.47
▸ HSPA5 P11021 1/20 0.47
▸ HSPA8 P11142 1/20 0.47
▸ RXFP1 Q9HBX9 1/20 0.47
▸ DOT1L Q8TEK3 1/20 0.47
▸ DCLK1 O15075 1/20 0.47
▸ DAPK3 O43293 1/20 0.47
▸ DYRK3 O43781 1/20 0.47
▸ CDK1 P06493 1/20 0.47
▸ ROS1 P08922 1/20 0.47
▸ RPS6KB1 P23443 1/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ FLT3 P36888 1/20 0.47
▸ CSNK1A1 P48729 1/20 0.47
▸ CSNK1D P48730 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11213318 1.00 ADA (0.50) ADAATG7TP53SMN1; SMN2ADK
SCHEMBL9350433 0.89 ATG7 (0.53) ADAATG7SMN1; SMN2ADKSLC29A1
SCHEMBL11210952 0.89 SLC29A1 (0.49) ADAATG7SLC29A1
SCHEMBL30935868 0.88 ADA (0.47) ADAATG7ADKSLC29A1HSPA5
SCHEMBL30935809 0.87 SLC29A1 (0.50) ADAATG7SLC29A1
SCHEMBL29273711 0.87 SLC29A1 (0.50) ADAATG7SLC29A1
SCHEMBL29273715 0.85 SLC29A1 (0.52) ADAADKSLC29A1
SCHEMBL30935808 0.85 SLC29A1 (0.52) ADAADKSLC29A1
SCHEMBL11210320 0.84 SLC29A1 (0.48) ADASLC29A1
SCHEMBL29273714 0.84 SLC29A1 (0.64) ATG7ADKSLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118355022-A Nucleoside analogues for the treatment of parasitic infections 安特卫普大学 2024-07-16 — — CN disclosed
EP-0021293-B1 4-SUBSTITUTED THIO-1-BETA-D-RIBOFURANOSYLPYRAZOLO(3,4-D) PYRIMIDINES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS AND MEDICAL USES THE WELLCOME FOUNDATION LIMITED (GB) 1983-09-07 — — EP disclosed
US-4299823-A TREATMENT OF COCCIDIOSIS BURROUGHS WELLCOME CO. (US) 1981-11-10 — — US disclosed
US-4299824-A TREATMENT OF COCCIDIOSIS BURROUGHS WELLCOME CO. (US) 1981-11-10 — — US disclosed
EP-0021293-A2 4-Substituted thio-1-beta-D-ribofuranosylpyrazolo(3,4-D) pyrimidines, processes for their preparation, pharmaceutical formulations and medical uses THE WELLCOME FOUNDATION LIMITED (GB) 1981-01-07 — — EP disclosed
Send feedback